• Profile
Close

Requirement of longer term antiviral therapy in patients with cytomegalovirus anterior uveitis with corneal endothelial cell damage

Clinical Ophthalmology Aug 01, 2018

Harada Y, et al. - Authors gauged the effectiveness of therapy in patients with cytomegalovirus (CMV) anterior uveitis. Findings suggested a likeliness of the patients with corneal endothelial cell loss to require longer-term antiviral therapy than those without endothelial damage. Moreover, the detection of CMV DNA in aqueous humor by polymerase chain reaction was required by the definitive diagnosis of CMV anterior uveitis, one-fifth of patients in the present study tested negative on initial examination.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay